Skip to content

Effect of the LumbaCure® Intervention on Elderly Patients Suffering From cLBP.

Exploratory Clinical Investigation of the LumbaCure® Medical Device Used in Elderly People Suffering From Chronic Low Back Pain.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06203886
Acronym
LumbaCure2303
Enrollment
10
Registered
2024-01-12
Start date
2023-12-11
Completion date
2024-07-18
Last updated
2024-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

The goal of this investigation is to evaluate the safety and efficacy of the LumbaCure® device in elderly people suffering from low back pain. The study is being carried out at several sites, in nursing homes, in order to reach the elderly patients most at risk of a sedentary lifestyle.

Interventions

DEVICELumbaCure

LumbaCure® is a device developed to induce specific mobilization of the lower back in patients requiring physical rehabilitation for orthopaedic disorders, particularly chronic low back pain.

Sponsors

Odix
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic or sub-acute low back pain (without red flag) * The subject, a resident or worker at the investigation site (nursing home), over 60 years of age * Ability to communicate with the physiotherapist. * Ability to remain in a sitting position for at least 10 minutes. * A level of back pain \> 2 on the numerical pain rating scale

Exclusion criteria

* Suspected or confirmed serious pathology (infection, fracture, cancer, inflammatory arthritis, ....) related to the back/spine. * Body weight \> 120 kg * Subject is non-ambulatory or has severely reduced mobility. * Dominant component of radicular pain (common lumbago with distal radiation below the knee) * Radiculopathy * Severe cardiorespiratory disease * Dementia or significant cognitive impairment that prevents the participant from giving consent, completing study questionnaires or complying with recommendations. * Fracture or operation less than 3 months old of the spine, pelvis, hip or leg bones. * Known vertebral pathology other than osteoarthritis. * Major neurological disease, movement or motor neuron disorders * Fibromyalgia or other systemic rheumatic disease * Recent history of stroke or heart failure, unstable heart condition * Uncontrolled substance abuse disorders * Invasive procedures to relieve pain in the last 3 months * Acute or terminal illness * Any other medical condition considered by the study team to be a contraindication to the study.

Design outcomes

Primary

MeasureTime frameDescription
Low back painChange between baseline and Visit 3 (Day 28)Mean intensity of low back pain during the last week, assessed on a numerical pain rating scale from 0 to 10

Secondary

MeasureTime frameDescription
Functional mobilityBetween baseline and visit 3 (day 28)Change in the time taken to complete the time up and go (TUG) test. The TUG consists of measuring the time it takes a person to get up from a chair, walk 3 metres at their usual pace, turn around, return to the chair and sit down. Two attempts are made and the best time is recorded
Low back painBetween baseline and each week through study completion, one month.Weekly changes from baseline in mean intensity of low back pain during the last week, assessed on a numerical pain rating scale from 0 to 10.
Overall patient satisfaction with the LumbaCure® interventionEnd of intervention period [Day 28]A single satisfaction score will be calculated at the end of the intervention period based on a series of three questions : * How satisfied or dissatisfied are you with the ability of the LumbaCure® procedure to improve your lower back pain (7 point scale)? * How satisfied or dissatisfied are you with the ability of the LumbaCure® procedure to improve your mobility? * How would you rate your overall experience with the LumbaCure® device (7-point scale)?
Risk of fallingBetween baseline and the end of the investigation,visit 3 [Day 28]Change in the risk of falling between baseline and the end of the intervention period, visit 3 (day 28), assessed by the Tinetti test. This test is a comprehensive assessment of both balance and gait. It assesses the patient's ability to change position, maintain balance in different situations and walk.
Overall satisfaction of the physiotherapist with the LumbaCure® interventionEnd of intervention period [Day 28]A single satisfaction score will be reported at the end of the intervention period by the physiotherapist: * How satisfied or dissatisfied are you with the ability of the LumbaCure® device intervention to improve your patient's low back pain condition (7 point scale)? * To what extent are you satisfied or dissatisfied with the ability of the LumbaCure® device to improve your patient's mobilisation (7-point scale)?

Other

MeasureTime frameDescription
Safety of the devicethrough study completion, one monthThe number, intensity and severity of adverse events are reported before each LumbaCure session.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026